This inventor holds 1 USPTO granted patent. Top assignees: Queensland Institute of Medical Research, Southern Adelaide Local Health Network, The Trustees of Flinders University. Active years: 2025.
Company Filing History:
1 out of 31 
1 out of 1 
1 out of 29 
Years Active: 2025
Title: Stuart MacGregor: Innovator in Glaucoma Risk Assessment
Introduction
Stuart MacGregor is a notable inventor based in Kedron, Australia. He has made significant contributions to the field of medical research, particularly in the assessment of glaucoma risk. His innovative approach combines genetic analysis with clinical assessments to provide a comprehensive understanding of glaucoma susceptibility.
Latest Patents
Stuart MacGregor holds a patent for "Methods and systems for assessing the risk of glaucoma." This patent outlines a method for determining a risk score for primary open angle glaucoma based on the genetic content of a subject at various selected genetic loci or markers. The method assesses the risk of glaucoma by considering genetic associations with glaucoma, increased intraocular pressure, and other relevant factors. This innovative approach has the potential to enhance early detection and management of glaucoma.
Career Highlights
Throughout his career, Stuart MacGregor has worked with esteemed institutions such as the Trustees of Flinders University and the Queensland Institute of Medical Research. His work has focused on integrating genetic research with clinical practices to improve patient outcomes in ophthalmology.
Collaborations
Stuart has collaborated with notable colleagues, including Jamie Evan Craig and Alex William Hewitt. These partnerships have fostered advancements in research and innovation within the field of glaucoma.
Conclusion
Stuart MacGregor's contributions to glaucoma risk assessment through his patented methods exemplify the intersection of genetics and clinical practice. His work continues to influence the field and improve the understanding of glaucoma risk factors.